Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
The DNA damage response

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 1658

Dr Helge Gad - Karolinska Institutet, Stockholm, Sweden

Dr Gad describes his research investigating inhibitors for DNA repair proteins in cancer cells, at the 3rd EurocanPlatform Translational Research Course. He explains what significance this could have in clinical practise, particularly in terms of developing new drugs for instance with PARP inhibitors at the Helleday Laboratory.

He also outlines the next steps and what obstacles they face in this line of research.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation